{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T03:15:45Z","timestamp":1792552545949,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2003,1,10]],"date-time":"2003-01-10T00:00:00Z","timestamp":1042156800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2003,2]]},"DOI":"10.1007\/s00467-002-1035-7","type":"journal-article","created":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T03:18:12Z","timestamp":1576120692000},"page":"92-96","source":"Crossref","is-referenced-by-count":126,"title":["Response to Shiga toxin 1 and 2 in a baboon model of hemolytic uremic syndrome"],"prefix":"10.1007","volume":"18","author":[{"given":"Richard L.","family":"Siegler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom G.","family":"Obrig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore J.","family":"Pysher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vernon L.","family":"Tesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel D.","family":"Denkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fletcher B.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2003,1,10]]},"reference":[{"key":"1035_CR1","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1017\/S0950268800066462","volume":"99","author":"Scotland","year":"1987","unstructured":"Scotland SM, Willshaw GA, Smith HR, Rowe B (1987) Properties of strains of Escherichia coli belonging to serogroup O157 with special reference to production of Vero cytotoxins VT1 and VT2. Epidemiol Infect 99:613\u2013624","journal-title":"Epidemiol Infect"},{"key":"1035_CR2","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1001\/jama.1989.03430030043031","volume":"262","author":"Ostroff","year":"1989","unstructured":"Ostroff SM, Kobayashi JM, Lewis JH (1989) Infections with Escherichia coli O157:H7 in Washington State. The first year of statewide disease surveillance. JAMA 262:355\u2013359","journal-title":"JAMA"},{"key":"1035_CR3","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1136\/adc.65.7.722","volume":"65","author":"Kleanthous","year":"1990","unstructured":"Kleanthous H, Smith HR, Scotland SM, Gross RJ, Rowe B, Taylor CM, Milford DV (1990) Haemolytic uraemic syndromes in the British Isles, 1985\u20138: association with Verocytotoxin producing Escherichia coli. 2. Microbiological aspects. Arch Dis Child 65:722\u2013727","journal-title":"Arch Dis Child"},{"key":"1035_CR4","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0022-3476(05)81609-9","volume":"116","author":"Cimolai","year":"1990","unstructured":"Cimolai N, Carter JE, Morrison BJ (1990) Risk factors for the progression of Escherichia coli O157:H7 enteritis to hemolytic-uremic syndrome. J Pediatr 116:589\u2013592","journal-title":"J Pediatr"},{"key":"1035_CR5","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0882-4010(90)90083-3","volume":"9","author":"Barrett","year":"1990","unstructured":"Barrett TJ, Potter ME, Strockbine NA (1990) Evidence for participation of the macrophage in Shiga-like toxin II-induced lethality in mice. Microb Pathog 9:95\u2013103","journal-title":"Microb Pathog"},{"key":"1035_CR6","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1128\/IAI.61.8.3392-3402.1993","volume":"61","author":"Tesh","year":"1993","unstructured":"Tesh VL, Burris JA, Owens JW, Gordon VM, Wadolkowski EA, O'Brien AD, Samuel JE (1993) Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice. Infect Immun 61:3392\u20133402","journal-title":"Infect Immun"},{"key":"1035_CR7","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1093\/infdis\/172.5.1397","volume":"172","author":"Louise","year":"1995","unstructured":"Louise CB, Obrig TG (1995) Specific interaction of Escherichia coli O157:H7-derived Shiga-like toxin II with human renal endothelial cells. J Infect Dis 172:1397\u20131401","journal-title":"J Infect Dis"},{"key":"1035_CR8","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1182\/blood.V95.11.3396","volume":"95","author":"Te","year":"2000","unstructured":"Te Loo DMWM, Monnens LAH, Velden TJAM van der, Vermeer MA, Preyers F, Demacker PNM, Heuvel LPWJ van den, Hinsbergh VWM van (2000) Binding and transfer of verocytotoxin by polymorphonuclear leukocytes in hemolytic uremic syndrome. Blood 95:3396\u20133402","journal-title":"Blood"},{"key":"1035_CR9","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1681\/ASN.V124800","volume":"12","author":"Te","year":"2001","unstructured":"Te Loo DM, Hinsbergh VW van, Heuvel LP van den, Monnens LA (2001) Detection of verocytotoxin bound to circulating polymorphonuclear leukocytes of patients with hemolytic uremic syndrome. J Am Soc Nephrol 12:800\u2013806","journal-title":"J Am Soc Nephrol"},{"key":"1035_CR10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000187761","volume":"66","author":"Lingwood","year":"1994","unstructured":"Lingwood CA (1994) Verotoxin-binding in human renal sections. Nephron 66:21\u201328","journal-title":"Nephron"},{"key":"1035_CR11","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/358510a0","volume":"358","author":"Sandvig","year":"1992","unstructured":"Sandvig K, Garred O, Prydz K, Kozlov JV, Hansen SH, Deurs B van (1992) Retrograde transport of endocytosed Shiga toxin to the endoplasmic reticulum (letter). Nature 358:510\u2013512","journal-title":"Nature"},{"key":"1035_CR12","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1083\/jcb.140.4.733","volume":"140","author":"Lord","year":"1998","unstructured":"Lord JM, Roberts LM (1998) Toxin entry: retrograde transport through the secretory pathway. J Cell Biol 140:733\u2013736","journal-title":"J Cell Biol"},{"key":"1035_CR13","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1042\/bj2440287","volume":"244","author":"Obrig","year":"1987","unstructured":"Obrig TG, Moran TP, Brown JE (1987) The mode of action of Shiga toxin on peptide elongation of eukaryotic protein synthesis. Biochem J 244:287\u2013294","journal-title":"Biochem J"},{"key":"1035_CR14","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/S0031-3955(16)40096-9","volume":"42","author":"Siegler","year":"1995","unstructured":"Siegler RL (1995) The hemolytic uremic syndrome. Pediatr Clin North Am 42:1505\u20131529","journal-title":"Pediatr Clin North Am"},{"key":"1035_CR15","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0002-9440(10)65380-1","volume":"154","author":"Taylor","year":"1999","unstructured":"Taylor FB Jr, Tesh VL, DeBault L, Li A, Chang ACK, Kosanke SD, Pysher TJ, Siegler RL (1999) Characterization of the baboon responses to Shiga-like toxin (descriptive study of a new primate model of toxic responses to Stx-1). Am J Pathol 154:1285\u20131299","journal-title":"Am J Pathol"},{"key":"1035_CR16","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1681\/ASN.V1271458","volume":"12","author":"Siegler","year":"2001","unstructured":"Siegler RL, Pysher TJ, Tesh VL, Taylor FB Jr (2001) Response to single and divided doses of Shiga toxin-1 in a primate model of hemolytic uremic syndrome. J Am Soc Nephrol 12:1458\u20131467","journal-title":"J Am Soc Nephrol"},{"key":"1035_CR17","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1159\/000046288","volume":"21","author":"Siegler","year":"2001","unstructured":"Siegler RL, Pysher TJ, Lou R, Tesh VL, Taylor FB Jr (2001) Response to Shiga toxin-1, with and without lipopolysaccharide, in a primate model of hemolytic uremic syndrome. Am J Nephrol 21:420\u2013425","journal-title":"Am J Nephrol"},{"key":"1035_CR18","unstructured":"Tesh VL, Samuel JE, Burris JA, Owens JW, Taylor FBJ, Siegler RL (1994) Quantitation and localization of shiga toxin\/shiga-like toxin-binding glycolipid receptors in human and baboon tissues. In: Recent advances in verocytotoxin-producing Escherichia coli infections. Elsevier, Bergamo"},{"key":"1035_CR19","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1016\/S0021-9258(19)67839-7","volume":"266","author":"Head","year":"1991","unstructured":"Head SC, Karmali MA, Lingwood CA (1991) Preparation of VT1 and VT2 hybrid toxins from their purified dissociated subunits. J Biol Chem 266:3617\u20133621","journal-title":"J Biol Chem"},{"key":"1035_CR20","first-page":"189","volume":"25","author":"Lingwood","year":"1993","unstructured":"Lingwood CA (1993) Verotoxins and their glycolipid receptors. Adv Lipid Res 25:189\u2013211","journal-title":"Adv Lipid Res"},{"key":"1035_CR21","doi-asserted-by":"publisher","first-page":"42915","DOI":"10.1074\/jbc.M106015200","volume":"276","author":"Nakajima","year":"2001","unstructured":"Nakajima H, Kiyokawa N, Katagiri YU, Taguchi T, Suzuki T, Sekino T, Mimori K, Ebata T, Saito M, Nakao H, Takeda T, Fujimoto J (2001) Kinetic analysis of binding between Shiga toxin and receptor glycolipid Gb3Cer by surface plasmon resonance. J Biol Chem 276:42915\u201342922","journal-title":"J Biol Chem"},{"key":"1035_CR22","doi-asserted-by":"crossref","first-page":"732","DOI":"10.3109\/07357909309046948","volume":"11","author":"Lotz","year":"1993","unstructured":"Lotz M (1993) Interleukin-6. Cancer Invest 11:732\u2013742","journal-title":"Cancer Invest"},{"key":"1035_CR23","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1046\/j.1523-1755.1998.00118.x","volume":"54","author":"Hughes","year":"1998","unstructured":"Hughes AK, Stricklett PK, Kohan DE (1998) Shiga toxin-1 regulation of cytokine production by human proximal tubule cells. Kidney Int 54:1093\u20131106","journal-title":"Kidney Int"},{"key":"1035_CR24","first-page":"275","volume":"5","author":"Mestries","year":"1994","unstructured":"Mestries JC, Kruithof EKO, Gascon MP, Herodin F, Agay D, Ythier A (1994) In vivo modulation of coagulation and fibrinolysis by recombinant glycosylated human interleukin-6 in baboons. Eur Cytokine Netw 5:275\u2013281","journal-title":"Eur Cytokine Netw"},{"key":"1035_CR25","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1365-2141.1994.tb04733.x","volume":"86","author":"Robson","year":"1994","unstructured":"Robson SC, Shepard EG, Kirsch RE (1994) Fibrin degradation product D-dimer induces the synthesis and release of biologically active Il-\u00df, Il-6 and plasminogen activator inhibitors from monocytes in vitro. Br J Haematol 86:322\u2013326","journal-title":"Br J Haematol"},{"key":"1035_CR26","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1084\/jem.179.4.1253","volume":"179","author":"Poll","year":"1994","unstructured":"Poll T van der, Levi M, Hack CE, Cate H ten, Deventer SJH van, Eerenberg AJM, Groot ER de, Jansen J, Gallati H, B\u00fcller HR, Cate JW ten, Aarden LA (1994) Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees. J Exp Med 179:1253\u20131259","journal-title":"J Exp Med"},{"key":"1035_CR27","doi-asserted-by":"crossref","first-page":"C110","DOI":"10.1007\/BF00868714","volume":"9","author":"Karpman","year":"1995","unstructured":"Karpman D, Connell H, Svensson M, Alm P, Scheutz F, Svanborg C (1995) The role of endotoxin and Shiga-like toxin in a mouse model of Escherichia coli O157:H7 infection (abstract). Pediatr Nephrol 9:C110","journal-title":"Pediatr Nephrol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-002-1035-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-002-1035-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-002-1035-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T07:00:43Z","timestamp":1665212443000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-002-1035-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1,10]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,2]]}},"alternative-id":["1035"],"URL":"https:\/\/doi.org\/10.1007\/s00467-002-1035-7","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,1,10]]}}}